Annals of Neurology Journal

2 downloads 0 Views 753KB Size Report
Acrobat Reader, the free Internet download software from Adobe, DOES NOT .... J_ID: ZAY Customer A_ID: 11-0684 Cadmus Art: ANA22503 Date: 13-June-11.
Annals of Neurology Journal Copy of e-mail Notification

Your article 11-0684 (22503) from Annals of Neurology is available for download _______________________________________ Annals of Neurology © Published by Wiley-Liss Dear Sir or Madam, Please refer to this URL address http://115.111.50.156/jw/retrieval.aspx?pwd=958063b5af3b Login: your e-mail address Password: 958063b5af3b The site contains 1 file. You will need to have Adobe Acrobat Reader software to read these files. This is free software and is available for user downloading at http://www.adobe.com/products/acrobat/readstep.html. If you have the Notes annotation tool (not contained within Acrobat reader), you can make corrections electronically and return them to Wiley as an e-mail attachment (see the Notes tool instruction sheet). This file contains: Author Instructions Checklist Adobe Acrobat Users - NOTES tool sheet Reprint Order Information Copyright Transfer Agreement A copy of your page proofs for your article After printing the PDF file, please read the page proofs carefully and: 1) indicate changes or corrections in the margin of the page proofs; 2) answer all queries (footnotes A,B,C, etc.) on the last page of the PDF proof; 3) proofread any tables and equations carefully; 4) check that any Greek, especially 'mu', has translated correctly. Within 48 hours, please return the following to the address given below: 1) original PDF set of page proofs, 2) print quality hard copy figures for corrections (we CANNOT accept figures on disk at this stage), 3) Signed Copyright Transfer Agreement, 4) Return fax form

Annals of Neurology Journal Copy of e-mail Notification

Return to: Dennis Velasco Production Editor John Wiley & Sons, Inc. 111 River Street, 8th Floor Hoboken, NJ 07030 TEL: (201) 748-8891 FAX: (201) 748-6182 E-mail: [email protected] If you experience technical problems, please contact Teressa Beard (e-mail: [email protected]). If you have any questions regarding your article, please contact me. PLEASE ALWAYS INCLUDE YOUR ARTICLE NO. (11-0684.22503) WITH ALL CORRESPONDENCE. This e-proof is to be used only for the purpose of returning corrections to the publisher. Sincerely, Dennis Velasco Production Editor John Wiley & Sons, Inc. 111 River Street, 8th Floor Hoboken, NJ 07030 TEL: (201) 748-8891 FAX: (201) 748-6182 E-mail: [email protected]

111 RIVER STREET, HOBOKEN,NJ 07030 ***NOTICE TO AUTHORS! IMMEDIATE RESPONSE REQUIRED*** Please follow these instructions to avoid delay of publication. Electronic Proofing, Annals of Neurology READ PROOFS CAREFULLY • This will be your only chance to review these proofs. • Please note that the volume and page numbers shown on the proofs are for position only. ANSWER ALL QUERIES ON PROOFS (Queries for you to answer are attached as the last page of your proof.) • Mark all corrections directly on the proofs. Note that excessive author alterations may ultimately result in delay of publication and extra costs may be charged to you. CHECK FIGURES AND TABLES CAREFULLY • Check size, numbering, and orientation of figures. • All images in the PDF are downsampled (reduced to lower resolution and file size) to facilitate Internet delivery. These images will appear at higher resolution and sharpness in the printed article. • Review figure legends to ensure that they are complete. • Check all tables. Review layout, title, and footnotes. PROOFS RETURN CTA (If you have not already signed one) RETURN WITHIN 48 HOURS OF RECEIPT VIA FAX TO 201-748-6182 QUESTIONS?

Dennis Velasco, Production Editor Phone: 201-748-8891 E-mail: [email protected] Refer to journal acronym and article production number

Softproofing for advanced Adobe Acrobat Users

- NOTES tool

NOTE: ACROBAT READER FROM THE INTERNET DOES NOT CONTAIN THE NOTES TOOL USED IN THIS PROCEDURE.

Acrobat annotation tools can be very useful for indicating changes to the PDF proof of your article. By using Acrobat annotation tools, a full digital pathway can be maintained for your page proofs. The NOTES annotation tool can be used with either Adobe Acrobat 6.0 or Adobe Acrobat 7.0. Other annotation tools are also available in Acrobat 6.0, but this instruction sheet will concentrate on how to use the NOTES tool. Acrobat Reader, the free Internet download software from Adobe, DOES NOT contain the NOTES tool. In order to softproof using the NOTES tool you must have the full software suite Adobe Acrobat Exchange 6.0 or Adobe Acrobat 7.0 installed on your computer. Steps for Softproofing using Adobe Acrobat NOTES tool: 1. Open the PDF page proof of your article using either Adobe Acrobat Exchange 6.0 or Adobe Acrobat 7.0. Proof your article on-screen or print a copy for markup of changes. 2. Go to Edit/Preferences/Commenting (in Acrobat 6.0) or Edit/Preferences/Commenting (in Acrobat 7.0) check “Always use login name for author name” option. Also, set the font size at 9 or 10 point. 3. When you have decided on the corrections to your article, select the NOTES tool from the Acrobat toolbox (Acrobat 6.0) and click to display note text to be changed, or Comments/Add Note (in Acrobat 7.0). 4. Enter your corrections into the NOTES text box window. Be sure to clearly indicate where the correction is to be placed and what text it will effect. If necessary to avoid confusion, you can use your TEXT SELECTION tool to copy the text to be corrected and paste it into the NOTES text box window. At this point, you can type the corrections directly into the NOTES text box window. DO NOT correct the text by typing directly on the PDF page. 5. Go through your entire article using the NOTES tool as described in Step 4. 6. When you have completed the corrections to your article, go to Document/Export Comments (in Acrobat 6.0) or Comments/Export Comments (in Acrobat 7.0). Save your NOTES file to a place on your harddrive where you can easily locate it. Name your NOTES file with the article number assigned to your article in the original softproofing e-mail message. 7. When closing your article PDF be sure NOT to save changes to original file. 8. To make changes to a NOTES file you have exported, simply re-open the original PDF proof file, go to Document/Import Comments and import the NOTES file you saved. Make changes and reexport NOTES file keeping the same file name. 9. When complete, attach your NOTES file to a reply e-mail message. Be sure to include your name, the date, and the title of the journal your article will be printed in.

Additional reprint purchases Should you wish to purchase additional copies of your article, please click on the link and follow the instructions provided: https://caesar.sheridan.com/reprints/redir.php?pub=10089&acro=ANA Corresponding authors are invited to inform their co-authors of the reprint options available. Please note that regardless of the form in which they are acquired, reprints should not be resold, nor further disseminated in electronic form, nor deployed in part or in whole in any marketing, promotional or educational contexts without authorization from Wiley. Permissions requests should be directed to mail to: [email protected] For information about ‘Pay-Per-View and Article Select’ click on the following link: http://wileyonlinelibrary.com/aboutus/ppv-articleselect.html

Annals of Neurology Authorship Responsibility, Financial Disclosure, and Copyright Transfer Manuscript Number: Manuscript Title: Corresponding Author: Address: Each author must read and sign the following statements: (1) authorship responsibility; (2) financial disclosure; and (3a) copyright transfer or (3b) federal employment. If necessary, photocopy this document and distribute to coauthors for their original ink signatures. Please compile all forms, include them with the manuscript, and send to: Production Editor, Annals of Neurology, John Wiley & Sons, 111 River Street (8-02), Hoboken, NJ 07030 USA, 201-748-6182 fax.

1. Authorship Responsibility: I certify that I have participated sufficiently in the conception and design of this work, the analysis of the data (where applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed this manuscript (accepted version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. Neither this manuscript nor one with substantially similar content under my authorship has been published or will be submitted for publication elsewhere while under consideration by Annals of Neurology, except as described in an attachment. Furthermore, I attest that I shall produce the data on which the manuscript is based for examination by the editors or their assignees should they request it. Author Signatures

Date

Author Signatures

Date

2. Financial Disclosure: I certify that any affiliations with or involvement (either competitive or amiable) in any organization or entity with a direct financial interest in the subject matter or materials discussed in the manuscript (e.g., employment, consultancies, stock ownership, honoraria, expert testimony, etc.) are noted below. Otherwise, my signature indicates that I have no such financial interest. All financial research or project support is identified in an acknowledgment in the manuscript. Statement of Financial Interest: (If more space is needed, submit a signed attachment.)

Author Signatures

Date

Author Signatures

Date

3a. Copyright: In consideration of Annals of Neurology reviewing and editing this submission, the author(s) undersigned hereby transfer(s) or otherwise convey(s) copyright ownership in all print and electronic formats to John Wiley and Sons, Inc. in the event that such work is accepted for publication in Annals of Neurology. Author Signatures

Date

Author Signatures

Date

3b. U.S. Federal Employment: I was an employee of the U.S. federal government when this work was conducted and prepared for publication. Therefore, it is not protected by the Copyright Act, and there is no copyright; thus, ownership cannot be transferred. Author Signatures

Date

Author Signatures

Date

These proofs have been typeset using the original figure files transmitted to production when this article was accepted for publication. Please review and mark your approval of each figure individually within your proof corrections. Should you need further assistance, please contact by e-mail [email protected]. Because of the high cost of color printing we can only print figures in color if authors cover the expense. If you have submitted color figures please indicate your consent to cover the cost on the table listed below by marking the box corresponding to the approved cost on the table. The first page of color is $1000 USD and subsequent color pages are an additional $500 USD per printed page. Please note, all color images will be reproduced online at no charge, whether or not you opt for color printing. You will be invoiced for color charges once the article has been published in print. Failure to return this form with your article proofs will delay the publication of your article. JOURNAL

ANA

MS. NO.

NO. COLOR PAGES

MANUSCRIPT TITLE AUTHOR(S) No. Color Pages Color Charge No. Color Pages Color Charge No. Color Pages Color Charge 1 5 9 $1000 $3000 $5000 2 6 0 10 $5500 $1500 $3500 3 7 11 $2000 $4000 $6000 4 8 $5500 $2500 $4500 12 6 ***Contact [email protected] for a quote if you have more than 12 pages of color*** Please print my figures color

Please print my figures in black and white

Please print the following figures in color and convert these figures to black and white Approved by Billing Address

E-mail Telephone Fax

J_ID: ZAY Customer A_ID: 11-0684 Cadmus Art: ANA22503 Date: 13-June-11

Stage:

Page: 1

EDITORIAL

Neurovascular Coupling: Key to Gait Slowing in Aging? lowing of gait is ubiquitous with aging,1–3 and mostly reflects disease effects on the neural pathways linking the cortical motor control areas to the peripheral effector organs like muscles and nerves.1 Clinical gait abnormalities of varying severity are present in almost one-third of community residing older adults.2 Neurological diseases such as strokes, Parkinson’s disease, or peripheral neuropathy account almost one-half of clinically diagnosed gait abnormalities in older adults.2 Gait dysfunction in older persons, whether diagnosed by clinicians or manifesting as slowing of gait, are major contributors to falls, can lead to activity restriction, and are associated with increased risk of institutionalization and death.3–5 While clinical gait evaluation is a standard part of the neurological examination and an essential component of fall risk assessments,6 very little research on gait changes in aging from a neurological perspective has been done. Abnormal cerebrovascular hemodynamics and the presence of cerebrovascular disease in older adults have been suggested to be important links between gait disturbances and adverse events such as falls.7,8 Impaired cerebral blood flow regulation has been linked to slow gait in older adults.7 Cerebral white matter hyperintensities (WMH) are associated not only with cerebral vascular dysregulation but also with slow gait in aging.8 The cerebral vasculature is endowed with neurovascular control mechanisms that assure the blood supply of the brain is commensurate to the energy needs of its cellular constituents.9 It has been known for over a century that brain activity can increase local cerebral blood flow.10 Neurovascular coupling (NVC) refers to the relationship between local neural activity and subsequent changes in local cerebral blood flow.9,10 The magnitude and spatial location of blood flow changes are linked to changes in neural activity through a complex sequence of coordinated events involving neurons, glia, and vascular cells.10 Many vascular-based functional brain imaging techniques, such as functional magnetic resonance imaging, rely on this coupling to infer changes in neural activity. Cerebral blood flow or metabolic changes during various activities is used as a proxy for NVC in these methods. NVC is disrupted in many pathological conditions, such as hypertension, Alzheimer’s disease, and ischemic strokes.9

S

NVC might, hence, be an important mechanism mediating the association between cerebrovascular disease and gait disturbances in aging. In this issue of Annals of Neurology, Sorond and colleagues11 investigated the association between NVC and gait in older individuals with cerebral vascular dysregulation (as measured by cerebral vasoreactivity to hypercapnia using transcranial Doppler ultrasound probes). The investigators hypothesized that NVC would be attenuated in slow walkers and would be associated with the presence of WMH on neuroimaging. They enrolled 22 fast walkers (0.67m/sec) and 20 slow walkers (